Bio-Techne Corporation, a Minneapolis-based life science tools company trading on NASDAQ:TECH, filed a current report on August 12, 2026, disclosing its results of operations for the quarter and full year ended June 30, 2026, and announcing a cash dividend.

Key Highlights

  • Reporting Period: Results cover the quarter and fiscal year ended June 30, 2026.
  • Financial Results: A press release describing results of operations and financial condition as of June 30, 2026 was attached as Exhibit 99.1.
  • Cash Dividend: Bio-Techne announced a cash dividend, with details provided in a press release attached as Exhibit 99.2.
  • Signed By: The report was signed by Shane V. Bohnen, Senior Vice President, General Counsel and Secretary.
  • Registered Exchange: Common Stock is registered on NASDAQ under trading symbol TECH.

Bio-Techne Discloses Fiscal Year 2026 Financials and Declares Cash Dividend

Bio-Techne Corporation, headquartered at 614 McKinley Place NE, Minneapolis, Minnesota 55413, filed its current report with the SEC on August 12, 2026, covering two separate disclosures. Under Item 2.02, the company attached a press release as Exhibit 99.1, which the filing states describes the results of operations for both the fourth quarter and the full fiscal year ended June 30, 2026, as well as the company's financial condition as of that date. The specific financial figures are contained within the attached exhibit rather than in the body of the current report itself.

Under Item 8.01, the filing references a second press release, attached as Exhibit 99.2, announcing a cash dividend. The filing does not specify the dividend amount, payment date, or record date within the body of the current report. According to the filing, Bio-Techne is a Minnesota-incorporated entity with Commission File Number 0-17272 and IRS Employer Identification Number 41-1427402. The company is not classified as an emerging growth company under the applicable SEC definitions.

The filing includes a standard limitation noting that the information in the current report and its exhibits "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934," nor incorporated by reference into other filings except as expressly stated. Shane V. Bohnen, Senior Vice President, General Counsel and Secretary, signed the report on behalf of Bio-Techne Corporation on August 12, 2026.

What Was Disclosed

Bio-Techne filed a current report on August 12, 2026, attaching two press releases: one covering fiscal year 2026 results of operations and financial condition as of June 30, 2026, and a second announcing a cash dividend. Detailed figures appear in the attached exhibits.